default author photo

Masaki Imai

University of Tokyo - Division of Virology

Yayoi 1-1-1

Bunkyo-ku

Tokyo, Tokyo 113-8657

Japan

SCHOLARLY PAPERS

1

DOWNLOADS

45

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Chimeric hPIV2/Corona-Spike Nasal Vaccine Robustly Protects the Upper and Lower Airways Against SARS-CoV-2

Number of pages: 56 Posted: 11 Mar 2021
Junpei Ohtsuka, Masayuki Fukumura, Masaki Imai, Mitsuyo Maeda, Asami Eguchi, Ryoichi Ono, Tadashi Maemura, Mutsumi Ito, Seiya Yamayoshi, Yosky Kataoka, Yoshihiro Kawaoka and Tetsuya Nosaka
Mie University - Department of Microbiology and Molecular Genetics, Mie University - Department of Microbiology and Molecular Genetics, University of Tokyo - Division of Virology, RIKEN-JEOL Collaboration Center - Multi-Modal Microstructure Analysis Unit, RIKEN-JEOL Collaboration Center - Multi-Modal Microstructure Analysis Unit, Mie University - Department of Microbiology and Molecular Genetics, University of Tokyo - Division of Virology, University of Tokyo - Division of Virology, University of Tokyo - Division of Virology, RIKEN-JEOL Collaboration Center - Multi-Modal Microstructure Analysis Unit, University of Wisconsin-Madison - Influenza Research Institute and Mie University - Department of Microbiology and Molecular Genetics
Downloads 45 (1,133,231)

Abstract:

Loading...

nasal vaccine, mucosal immunity, SARS-CoV-2, COVID-19, hPIV2, replication-incompetent vector, viral vector, BC-PIV, herd immunity, cytoplasmic RNA vector